CE Symposium- Atherosclerotic Cardiovascular Disease, Heart Failure, and SGLT2 Inhibitors: Implementing Evidence-Based Treatment Strategies
This CE Symposium takes place on Friday, April 3, 2020, from 7:30 AM- 8:30 AM at the Caribe Royale, Caribbean Ballroom 4/5, 8101 World Center Drive, Orlando, Florida.
Cindy Lamendola, MSN, ANP-BC, FAHA, FPCNA
Nurse Practitioner and Clinical Research Coordinator
Stanford University School of Medicine
Darren McGuire, MD, MHSc
Professor of Internal Medicine
University of Texas Southwestern Medical Center
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program is accredited for 1 contact hour of continuing education. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.
PCNA and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals LP.
This educational activity is intended for Cardiovascular Nurse Practitioners, Nurses, and other clinicians attending the 2020 PCNA Annual Meeting.
Pre-registration is for planning purposes only. For additional CME activities and online cme courses visit http://www.CMEPlanet.com